Regulatory Roundup: USP Releases Proposed Supply Chain Guidelines
USP Releases Guidelines on Ensuring the Integrity of the Pharmaceutical Supply Chain.
The US Pharmacopeia has released proposed guidelines on ensuring the integrity of the pharmaceutical supply chain. The guidelines cover five main areas: good importation practices, counterfeit drugs and medical devices, best practices to combat counterfeit drug and medical devices, diversion and theft, and natural disasters. The guideline is open for public comment through May 31, 2012, and will appear in the Pharmacopeial Forum 38(2). A May 2012 USP workshop will address the comments received and the draft chapter.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
